AEON Biopharma CEO Buys 3 Million RSUs Amid Volatile Shares—A Sign of Optimism?
AEON Biopharma CEO’s 3 M RSU purchase signals long‑term confidence amid volatile stock, showing how executive alignment can stabilize shares.
3 minutes to read
AEON Biopharma Inc